MBI Share Price

Open 0.04 Change Price %
High 0.04 1 Day 0.00 0.00
Low 0.04 1 Week 0.00 0.00
Close 0.04 1 Month 0.00 0.00
Volume 113000 1 Year -0.02 -33.33
52 Week High 0.08
52 Week Low 0.03
MBI Important Levels
Resistance 2 0.04
Resistance 1 0.04
Pivot 0.04
Support 1 0.04
Support 2 0.04
CVE Canada Most Active Stocks
ROI 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PHM 0.28 7.69%
PHM 0.28 7.69%
PHM 0.28 7.69%
COD 0.07 0.00%
COD 0.07 0.00%
More..
CVE Canada Top Gainers Stocks
DVT 0.10 233.33%
DVT 0.10 233.33%
DVT 0.10 233.33%
DVT 0.10 233.33%
BVQ 0.02 100.00%
SBX 0.02 100.00%
SBX 0.02 100.00%
SBX 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
More..
CVE Canada Top Losers Stocks
NMG 0.00 -100.00%
NMG 0.00 -100.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
RMN 0.02 -50.00%
TIN 0.04 -50.00%
TIN 0.04 -50.00%
TIN 0.04 -50.00%
BMA 0.06 -40.00%
More..

Med Biogene Inc (CVE: MBI)

MBI Technical Analysis 1.5
As on 26th Apr 2017 MBI Share Price closed @ 0.04 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.05 & Buy for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS.
MBI Target for April
1st Target up-side 0.06
2nd Target up-side 0.07
3rd Target up-side 0.08
1st Target down-side 0.02
2nd Target down-side 0.01
3rd Target down-side N/A
MBI Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.medbiogene.com
MBI Address
MBI
580 Hornby Street
Suite 510
Vancouver, BC V6C 3B6
Canada
Phone: 800-641-3593
Fax: 888-646-2531
MBI Latest News
Checking the Signals on Shares of Med Biogene Inc. (MBI.VN)   Stock Rover   - 25th Apr 17
Med Biogene Inc. Enters Into Settlement Agreement With Helomics Corporation   Marketwired (press release)   - 29th Nov 16
Health IT company Tabula Rasa files for $115M IPO   MedCity News   - 05th Jan 16
From activist to CEO, how Iain Weir Jones landed the top job at Med Bio-Gene   Financial Post   - 20th Jun 15
Next Generation Cancer Diagnostics: Technologies and Global Markets   PR Newswire (press release)   - 04th Sep 14
The World Market for Cancer Diagnostics, 5th Edition: Precision and ...   PR Newswire (press release)   - 06th May 14
World Market for Molecular Diagnostics, 5th. Edition (Infectious Disease ...   PR Newswire (press release)   - 11th Feb 13
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition   PR Newswire (press release)   - 06th Aug 12
Sean McDonald   Smart Business Network   - 01st Oct 11
Med Biogene Inc. Stock (CVE:MBI) Advanced, But at What Cost?   HotStocked   - 07th Mar 11
Interactive Technical Analysis Chart Med Biogene Inc ( MBI CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Med Biogene Inc
MBI Business Profile
Med BioGene Inc., a life science company, focuses on managing the license and rights to the genomic-based clinical laboratory diagnostic tests. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that analyzes the molecular profile of a patient’s tumor to provide information to assist in tailoring treatment for that specific patient. The company has a collaboration agreement with the University Health Network. Med BioGene Inc. was founded in 2002 and is headquartered in Vancouver, Canada.